Lung cancer suppressor gene GPRC5A mediates p53 activity in non-small cell lung cancer cells in vitro
Er Jin(Hangzhou First People's Hospital), Shenglin Ma(North University of China)
Cited by 16
Related Papers
Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer (INFORM; C-TONG 0804)
|Journal of Thoracic Oncology|2015|44
Effect of Paris saponin I on radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line
|Oncology Letters|2014|39
Chalcomoracin inhibits cell proliferation and increases sensitivity to radiotherapy in human non-small cell lung cancer cells via inducing endoplasmic reticulum stress-mediated paraptosis
|Acta Pharmacologica Sinica|2020|36
Role of transcription factor FOXA1 in non‑small cell lung cancer
|Molecular Medicine Reports|2017|28
Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer
|Journal of Translational Medicine|2019|26